Minimal Contribution of Fasting Hyperglycemia to the Incidence of Type 2 Diabetes in Subjects With Normal 2-h Plasma Glucose
OBJECTIVE: To assess the relative contribution of increased fasting and postload plasma glucose concentrations to the incidence of type 2 diabetes in subjects with a normal 2-h plasma glucose concentration. RESEARCH DESIGN AND METHODS: A total of 3,450 subjects with 2-h plasma glucose concentration...
Saved in:
Published in | Diabetes care Vol. 33; no. 3; pp. 557 - 561 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
Alexandria, VA
American Diabetes Association
01.03.2010
|
Subjects | |
Online Access | Get full text |
ISSN | 0149-5992 1935-5548 1935-5548 |
DOI | 10.2337/dc09-1145 |
Cover
Loading…
Abstract | OBJECTIVE: To assess the relative contribution of increased fasting and postload plasma glucose concentrations to the incidence of type 2 diabetes in subjects with a normal 2-h plasma glucose concentration. RESEARCH DESIGN AND METHODS: A total of 3,450 subjects with 2-h plasma glucose concentration <140 mg/dl at baseline were followed up in the San Antonio Heart Study (SAHS) and the Botnia Study for 7-8 years. The incidence of type 2 diabetes at follow-up was related to the fasting, 1-h, and 2-h plasma glucose concentrations. RESULTS: In subjects with 2-h plasma glucose <140 mg/dl, the incidence of type 2 diabetes increased with increasing fasting plasma glucose (FPG) and 1-h and 2-h plasma glucose concentrations. In a multivariate logistic analysis, after adjustment for all diabetes risk factors, the FPG concentration was a strong predictor of type 2 diabetes in both the SAHS and the Botnia Study (P < 0.0001). However, when the 1-h plasma glucose, but not 2-h plasma glucose, concentration was added to the model, FPG concentration was no longer a significant predictor of type 2 diabetes in both studies (NS). When subjects were matched for the level of 1-h plasma glucose concentration, the incidence of type 2 diabetes markedly increased with the increase in 1-h plasma glucose, but the increase in FPG was not associated with a significant increase in the incidence of type 2 diabetes. CONCLUSIONS: An increase in postload glycemia in the normal range is associated with an increase in the incidence of type 2 diabetes. After controlling for 1-h plasma glucose concentration, the increase in FPG concentration is not associated with an increase in the incidence of type 2 diabetes. |
---|---|
AbstractList | OBJECTIVE To assess the relative contribution of increased fasting and postload plasma glucose concentrations to the incidence of type 2 diabetes in subjects with a normal 2-h plasma glucose concentration. RESEARCH DESIGN AND METHODS A total of 3,450 subjects with 2-h plasma glucose concentration <140 mg/dl at baseline were followed up in the San Antonio Heart Study (SAHS) and the Botnia Study for 7-8 years. The incidence of type 2 diabetes at follow-up was related to the fasting, 1-h, and 2-h plasma glucose concentrations. RESULTS In subjects with 2-h plasma glucose <140 mg/dl, the incidence of type 2 diabetes increased with increasing fasting plasma glucose (FPG) and 1-h and 2-h plasma glucose concentrations. In a multivariate logistic analysis, after adjustment for all diabetes risk factors, the FPG concentration was a strong predictor of type 2 diabetes in both the SAHS and the Botnia Study (P < 0.0001). However, when the 1-h plasma glucose, but not 2-h plasma glucose, concentration was added to the model, FPG concentration was no longer a significant predictor of type 2 diabetes in both studies (NS). When subjects were matched for the level of 1-h plasma glucose concentration, the incidence of type 2 diabetes markedly increased with the increase in 1-h plasma glucose, but the increase in FPG was not associated with a significant increase in the incidence of type 2 diabetes. CONCLUSIONS An increase in postload glycemia in the normal range is associated with an increase in the incidence of type 2 diabetes. After controlling for 1-h plasma glucose concentration, the increase in FPG concentration is not associated with an increase in the incidence of type 2 diabetes. To assess the relative contribution of increased fasting and postload plasma glucose concentrations to the incidence of type 2 diabetes in subjects with a normal 2-h plasma glucose concentration. A total of 3,450 subjects with 2-h plasma glucose concentration < 140 mg/dl at baseline were followed up in the San Antonio Heart Study (SAHS) and the Botnia Study for 7-8 years. The incidence of type 2 diabetes at follow-up was related to the fasting, 1-h, and 2-h plasma glucose concentrations. In subjects with 2-h plasma glucose <140 mg/dl, the incidence of type 2 diabetes increased with increasing fasting plasma glucose (FPG) and 1-h and 2-h plasma glucose concentrations. In a multivariate logistic analysis, after adjustment for all diabetes risk factors, the FPG concentration was a strong predictor of type 2 diabetes in both the SAHS and the Botnia Study (P < 0.0001). However, when the 1-h plasma glucose, but not 2-h plasma glucose, concentration was added to the model, FPG concentration was no longer a significant predictor of type 2 diabetes in both studies (NS). When subjects were matched for the level of 1-h plasma glucose concentration, the incidence of type 2 diabetes markedly increased with the increase in 1-h plasma glucose, but the increase in FPG was not associated with a significant increase in the incidence of type 2 diabetes. An increase in postload glycemia in the normal range is associated with an increase in the incidence of type 2 diabetes. After controlling for 1-h plasma glucose concentration, the increase in FPG concentration is not associated with an increase in the incidence of type 2 diabetes. OBJECTIVE To assess the relative contribution of increased fasting and postload plasma glucose concentrations to the incidence of type 2 diabetes in subjects with a normal 2-h plasma glucose concentration. RESEARCH DESIGN AND METHODS A total of 3,450 subjects with 2-h plasma glucose concentration <140 mg/dl at baseline were followed up in the San Antonio Heart Study (SAHS) and the Botnia Study for 7-8 years. The incidence of type 2 diabetes at follow-up was related to the fasting, 1-h, and 2-h plasma glucose concentrations. RESULTS In subjects with 2-h plasma glucose <140 mg/dl, the incidence of type 2 diabetes increased with increasing fasting plasma glucose (FPG) and 1-h and 2-h plasma glucose concentrations. In a multivariate logistic analysis, after adjustment for all diabetes risk factors, the FPG concentration was a strong predictor of type 2 diabetes in both the SAHS and the Botnia Study (P < 0.0001). However, when the 1-h plasma glucose, but not 2-h plasma glucose, concentration was added to the model, FPG concentration was no longer a significant predictor of type 2 diabetes in both studies (NS). When subjects were matched for the level of 1-h plasma glucose concentration, the incidence of type 2 diabetes markedly increased with the increase in 1-h plasma glucose, but the increase in FPG was not associated with a significant increase in the incidence of type 2 diabetes. CONCLUSIONS An increase in postload glycemia in the normal range is associated with an increase in the incidence of type 2 diabetes. After controlling for 1-h plasma glucose concentration, the increase in FPG concentration is not associated with an increase in the incidence of type 2 diabetes.OBJECTIVE To assess the relative contribution of increased fasting and postload plasma glucose concentrations to the incidence of type 2 diabetes in subjects with a normal 2-h plasma glucose concentration. RESEARCH DESIGN AND METHODS A total of 3,450 subjects with 2-h plasma glucose concentration <140 mg/dl at baseline were followed up in the San Antonio Heart Study (SAHS) and the Botnia Study for 7-8 years. The incidence of type 2 diabetes at follow-up was related to the fasting, 1-h, and 2-h plasma glucose concentrations. RESULTS In subjects with 2-h plasma glucose <140 mg/dl, the incidence of type 2 diabetes increased with increasing fasting plasma glucose (FPG) and 1-h and 2-h plasma glucose concentrations. In a multivariate logistic analysis, after adjustment for all diabetes risk factors, the FPG concentration was a strong predictor of type 2 diabetes in both the SAHS and the Botnia Study (P < 0.0001). However, when the 1-h plasma glucose, but not 2-h plasma glucose, concentration was added to the model, FPG concentration was no longer a significant predictor of type 2 diabetes in both studies (NS). When subjects were matched for the level of 1-h plasma glucose concentration, the incidence of type 2 diabetes markedly increased with the increase in 1-h plasma glucose, but the increase in FPG was not associated with a significant increase in the incidence of type 2 diabetes. CONCLUSIONS An increase in postload glycemia in the normal range is associated with an increase in the incidence of type 2 diabetes. After controlling for 1-h plasma glucose concentration, the increase in FPG concentration is not associated with an increase in the incidence of type 2 diabetes. |
Audience | Professional |
Author | Stern, Michael P Groop, Leif Abdul-Ghani, Muhammad A DeFronzo, Ralph A Lyssenko, Valeriya Tuomi, Tiinamaija |
Author_xml | – sequence: 1 fullname: Abdul-Ghani, Muhammad A – sequence: 2 fullname: Stern, Michael P – sequence: 3 fullname: Lyssenko, Valeriya – sequence: 4 fullname: Tuomi, Tiinamaija – sequence: 5 fullname: Groop, Leif – sequence: 6 fullname: DeFronzo, Ralph A |
BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=22509189$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/20007945$$D View this record in MEDLINE/PubMed https://lup.lub.lu.se/record/1589074$$DView record from Swedish Publication Index oai:portal.research.lu.se:publications/3f60b1ca-54e2-4f06-83b4-e930c052f0d0$$DView record from Swedish Publication Index |
BookMark | eNqNk9tu1DAQhiNURA9wwQuABQLERVofk_gGqSr0IJWD1FZcWo4z2XXltRc7AVXi4XHYFmi1IBRZieJv_hmP_9kuNnzwUBSPCd6ljNV7ncGyJISLe8UWkUyUQvBmo9jChMtSSEk3i-2ULjHGnDfNg2KT5s9acrFVfH9vvV1ohw6CH6Jtx8EGj0KPDnUarJ-h46slxJm7MrCwGg0BDXNAJ97YDryBiTzPBKLordUtDJCQ9ehsbC_BDAl9tsMcfQhxykDLOfrkdFpodORGExI8LO732iV4dP3eKS4O350fHJenH49ODvZPS1MLPJSNaUltqppRwWhHONHCQCeJaEjDKhAAhnWSc1GJTouaUyGo4TWRlaDaYM52Cr3STd9gObZqGfOR45UK2qpliIN2KkICHc1cuVElUJly1uipGUmxvsItMVoJDlTxHleqYS1XIBk2WNAedzjnOP1rDjcu82qvtf9T7s1KLmstoDOQbyeXeavyWzveztUsfFW0oblpdRZ4dS0Qw5cR0qAWNhlwTnsIY1I1YxnFVZXJl_8keSV4RkkGn90BL8MYfb45RSnDTEoy5X2-gmbagbK-D7k8MymqfUpJXWEsJ6pcQ83AQz5LNndv8-9b_O4aPj9dtqVZG_Dkz_79atyN8zPw4hrQyWjXR509nX5zVGBJGpm5vRVnYkgpQq-MHX4aI1dgnSJYTTOophlU0wzmiNd3Im5E17FPV2yvg9KzmCu4OKOYMEwa3HDJ2A88zjcP |
CODEN | DICAD2 |
CitedBy_id | crossref_primary_10_1016_j_diabres_2021_108683 crossref_primary_10_1016_j_mcna_2010_11_002 crossref_primary_10_1007_s12018_012_9126_x crossref_primary_10_1016_j_diabres_2024_111856 crossref_primary_10_1111_j_1365_2265_2011_04159_x crossref_primary_10_1038_jhg_2013_14 crossref_primary_10_4158_EP_2019_0387 crossref_primary_10_2478_v10255_012_0004_6 crossref_primary_10_1002_dmrr_1025 crossref_primary_10_2337_dc11_0827 crossref_primary_10_1007_s00108_015_3737_5 crossref_primary_10_1016_j_diabres_2013_12_049 crossref_primary_10_1016_j_jcte_2019_100195 crossref_primary_10_1530_EJE_11_0827 crossref_primary_10_1371_journal_pone_0075807 crossref_primary_10_1111_jdi_12353 crossref_primary_10_1016_j_soard_2016_12_001 crossref_primary_10_1097_MCO_0000000000000307 crossref_primary_10_1007_s00592_012_0384_3 crossref_primary_10_1038_s41430_024_01457_1 crossref_primary_10_1016_j_diabres_2011_05_035 crossref_primary_10_1016_j_diabres_2018_09_017 crossref_primary_10_2337_db11_1785 crossref_primary_10_1016_j_jacl_2019_09_012 crossref_primary_10_1016_j_metabol_2010_06_017 crossref_primary_10_1007_s00125_016_4051_z crossref_primary_10_1016_j_diabres_2024_111589 crossref_primary_10_1016_j_diabres_2024_111941 crossref_primary_10_1016_j_jcjd_2023_05_009 crossref_primary_10_1016_S1957_2557_10_70124_3 crossref_primary_10_1111_dme_12356 crossref_primary_10_2337_dc09_2261 crossref_primary_10_1155_2014_436725 crossref_primary_10_1017_S0007114511006507 crossref_primary_10_1007_s00125_017_4453_6 crossref_primary_10_21518_2079_701X_2021_12_220_227 crossref_primary_10_1093_qjmed_hcv204 crossref_primary_10_1007_s11892_013_0422_8 crossref_primary_10_1111_cen_13443 crossref_primary_10_1111_jdi_12185 crossref_primary_10_1016_j_ejim_2010_07_008 crossref_primary_10_1530_EJE_15_1221 crossref_primary_10_1007_s12020_012_9830_9 |
Cites_doi | 10.1111/j.1464-5491.2008.02597.x 10.1093/oxfordjournals.aje.a113956 10.1016/j.diabres.2007.05.004 10.1007/s00125-003-1169-6 10.2337/dc07-1593 10.1001/archinte.159.13.1450 10.1007/s00125-002-1009-0 10.1046/j.1464-5491.2002.00835.x 10.1007/s00125-004-1339-1 10.1001/jama.1989.03430030048032 10.2337/diab.45.11.1585 10.2337/dc08-1264 10.1007/s00125-003-1263-9 10.2337/diacare.20.7.1183 10.2337/dc06-0438 10.1007/s00125-004-1454-z 10.2337/diacare.22.3.399 10.2337/db05-1200 10.2337/diabetes.48.11.2197 10.2337/dc06-1331 10.2337/dc08-0225 10.2337/dc05-2179 |
ContentType | Journal Article |
Copyright | 2015 INIST-CNRS COPYRIGHT 2010 American Diabetes Association Copyright American Diabetes Association Mar 2010 2010 by the American Diabetes Association. 2010 |
Copyright_xml | – notice: 2015 INIST-CNRS – notice: COPYRIGHT 2010 American Diabetes Association – notice: Copyright American Diabetes Association Mar 2010 – notice: 2010 by the American Diabetes Association. 2010 |
CorporateAuthor | Lunds universitet Profile areas and other strong research environments Translational Muscle Research Department of Clinical Sciences, Malmö Lund University Translationell muskelforskning Strategiska forskningsområden (SFO) EpiHealth: Epidemiology for Health EXODIAB: Excellence of Diabetes Research in Sweden Faculty of Medicine Strategic research areas (SRA) Medicinska fakulteten Profilområden och andra starka forskningsmiljöer Institutionen för kliniska vetenskaper, Malmö |
CorporateAuthor_xml | – name: Faculty of Medicine – name: Medicinska fakulteten – name: Strategiska forskningsområden (SFO) – name: Translationell muskelforskning – name: EpiHealth: Epidemiology for Health – name: Institutionen för kliniska vetenskaper, Malmö – name: Strategic research areas (SRA) – name: Lunds universitet – name: Translational Muscle Research – name: Profilområden och andra starka forskningsmiljöer – name: Lund University – name: EXODIAB: Excellence of Diabetes Research in Sweden – name: Profile areas and other strong research environments – name: Department of Clinical Sciences, Malmö |
DBID | FBQ AAYXX CITATION IQODW CGR CUY CVF ECM EIF NPM 3V. 7RV 7X2 7X7 7XB 88E 88I 8AF 8AO 8C1 8FE 8FH 8FI 8FJ 8FK 8G5 ABUWG AFKRA AN0 ATCPS AZQEC BEC BENPR BHPHI CCPQU DWQXO FYUFA GHDGH GNUQQ GUQSH HCIFZ K9- K9. KB0 M0K M0R M0S M0T M1P M2O M2P MBDVC NAPCQ PHGZM PHGZT PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI PRINS Q9U S0X 7S9 L.6 7X8 5PM ADTPV AOWAS D95 |
DOI | 10.2337/dc09-1145 |
DatabaseName | AGRIS CrossRef Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Nursing & Allied Health Database Agricultural Science Collection ProQuest Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Science Database (Alumni Edition) STEM Database ProQuest Pharma Collection Public Health Database ProQuest SciTech Collection ProQuest Natural Science Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Research Library ProQuest Central (Alumni) ProQuest Central UK/Ireland British Nursing Database Agricultural & Environmental Science Collection ProQuest Central Essentials ProQuest eLibrary (NC LIVE) ProQuest Central Natural Science Collection ProQuest One Community College ProQuest Central Health Research Premium Collection (ProQuest) Health Research Premium Collection (Alumni) ProQuest Central Student ProQuest Research Library SciTech Premium Collection Consumer Health Database (Alumni Edition) ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Database (Alumni Edition) Agricultural Science Database Consumer Health Database ProQuest Health & Medical Collection Healthcare Administration Database Proquest Medical Database ProQuest Research Library Science Database Research Library (Corporate) Nursing & Allied Health Premium ProQuest Central Premium ProQuest One Academic ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China ProQuest Central Basic SIRS Editorial AGRICOLA AGRICOLA - Academic MEDLINE - Academic PubMed Central (Full Participant titles) SwePub SwePub Articles SWEPUB Lunds universitet |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Agricultural Science Database Research Library Prep ProQuest Central Student ProQuest Central Essentials elibrary ProQuest AP Science SciTech Premium Collection ProQuest Central China Health Research Premium Collection Natural Science Collection Health & Medical Research Collection ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest Science Journals (Alumni Edition) ProQuest Family Health ProQuest One Academic Eastern Edition Agricultural Science Collection ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Hospital Collection (Alumni) Nursing & Allied Health Premium ProQuest Health & Medical Complete ProQuest One Academic UKI Edition ProQuest Nursing & Allied Health Source (Alumni) ProQuest One Academic ProQuest One Academic (New) ProQuest One Academic Middle East (New) SIRS Editorial ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing Research Library (Alumni Edition) ProQuest Natural Science Collection ProQuest Pharma Collection ProQuest Family Health (Alumni Edition) ProQuest Central Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Agricultural & Environmental Science Collection ProQuest Research Library ProQuest Public Health ProQuest Central Basic ProQuest Science Journals British Nursing Index with Full Text ProQuest Health Management ProQuest Nursing & Allied Health Source ProQuest SciTech Collection ProQuest Medical Library ProQuest Central (Alumni) AGRICOLA AGRICOLA - Academic MEDLINE - Academic |
DatabaseTitleList | MEDLINE Agricultural Science Database AGRICOLA MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 3 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database – sequence: 4 dbid: FBQ name: AGRIS url: http://www.fao.org/agris/Centre.asp?Menu_1ID=DB&Menu_2ID=DB1&Language=EN&Content=http://www.fao.org/agris/search?Language=EN sourceTypes: Publisher |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1935-5548 |
EndPage | 561 |
ExternalDocumentID | oai_portal_research_lu_se_publications_3f60b1ca_54e2_4f06_83b4_e930c052f0d0 oai_lup_lub_lu_se_3f60b1ca_54e2_4f06_83b4_e930c052f0d0 PMC2827507 1989832201 A221760097 20007945 22509189 10_2337_dc09_1145 US201301808493 |
Genre | Journal Article |
GroupedDBID | --- -ET ..I .55 .GJ .XZ 08P 0R~ 18M 29F 2WC 3O- 4.4 41~ 53G 5GY 5RE 5RS 5VS 6PF 7RV 7X2 7X7 88E 88I 8AF 8AO 8C1 8F7 8FE 8FH 8FI 8FJ 8G5 8R4 8R5 AAIKC AAKAS AAMNW AAQOH AAQQT AAWTL AAYEP AAYJJ ABOCM ABPPZ ABUWG ACGFO ACGOD ADBBV ADZCM AEGXH AENEX AERZD AFFNX AFKRA AFOSN AFRAH AHMBA AI. AIAGR ALIPV ALMA_UNASSIGNED_HOLDINGS AN0 AQUVI ATCPS AZQEC BAWUL BCR BCU BEC BENPR BHPHI BKEYQ BKNYI BLC BNQBC BPHCQ BTFSW BVXVI C1A CCPQU CS3 DIK DU5 DWQXO E3Z EBS EDB EJD EMOBN EX3 F5P FBQ FYUFA GNUQQ GUQSH GX1 H13 HCIFZ HMCUK HZ~ IAG IAO IEA IHR INH INR IOF IPO ITC J5H K9- KQ8 L7B M0K M0R M0T M1P M2O M2P M2Q M5~ N4W NAPCQ O5R O5S O9- OK1 OVD P2P PCD PEA PHGZT PQQKQ PROAC PSQYO Q2X RHI S0X SJFOW SV3 TDI TEORI TR2 TWZ UKHRP VH1 VVN W8F WH7 WHG WOQ WOW X7M YHG YOC ZCG ZGI ZXP ~KM AAFWJ AAYXX CITATION PHGZM IQODW CGR CUY CVF ECM EIF NPM PJZUB PPXIY PMFND 3V. 7XB 8FK K9. MBDVC PKEHL PQEST PQUKI PRINS Q9U 7S9 L.6 7X8 5PM ADTPV AOWAS D95 |
ID | FETCH-LOGICAL-c750t-8cb17c6732532d141a5ced91581836e5eec3d944565da5742552c4719652ac043 |
IEDL.DBID | 7X7 |
ISSN | 0149-5992 1935-5548 |
IngestDate | Thu Aug 21 06:44:11 EDT 2025 Thu Jul 03 05:06:55 EDT 2025 Thu Aug 21 18:15:44 EDT 2025 Thu Jul 10 23:25:12 EDT 2025 Fri Jul 11 06:43:09 EDT 2025 Sat Jul 26 02:15:17 EDT 2025 Tue Jun 17 21:12:43 EDT 2025 Thu Jun 12 23:53:50 EDT 2025 Tue Jun 10 20:24:44 EDT 2025 Mon Jul 21 05:56:51 EDT 2025 Wed Apr 02 07:16:23 EDT 2025 Thu Apr 24 23:05:27 EDT 2025 Tue Jul 01 04:20:21 EDT 2025 Thu Apr 03 09:45:55 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 3 |
Keywords | Endocrinopathy Type 2 diabetes Human Fasting Nutrition Metabolic diseases Glucose Normal Epidemiology Incidence Hyperglycemia Fast Endocrinology Glycemia |
Language | English |
License | CC BY 4.0 Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. See http://creativecommons.org/licenses/by-nc-nd/3.0/ for details. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c750t-8cb17c6732532d141a5ced91581836e5eec3d944565da5742552c4719652ac043 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
OpenAccessLink | https://pubmed.ncbi.nlm.nih.gov/PMC2827507 |
PMID | 20007945 |
PQID | 223039917 |
PQPubID | 47715 |
PageCount | 5 |
ParticipantIDs | swepub_primary_oai_portal_research_lu_se_publications_3f60b1ca_54e2_4f06_83b4_e930c052f0d0 swepub_primary_oai_lup_lub_lu_se_3f60b1ca_54e2_4f06_83b4_e930c052f0d0 pubmedcentral_primary_oai_pubmedcentral_nih_gov_2827507 proquest_miscellaneous_733282066 proquest_miscellaneous_46542821 proquest_journals_223039917 gale_infotracmisc_A221760097 gale_infotracgeneralonefile_A221760097 gale_infotracacademiconefile_A221760097 pubmed_primary_20007945 pascalfrancis_primary_22509189 crossref_citationtrail_10_2337_dc09_1145 crossref_primary_10_2337_dc09_1145 fao_agris_US201301808493 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2010-03-01 |
PublicationDateYYYYMMDD | 2010-03-01 |
PublicationDate_xml | – month: 03 year: 2010 text: 2010-03-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | Alexandria, VA |
PublicationPlace_xml | – name: Alexandria, VA – name: United States – name: Alexandria |
PublicationTitle | Diabetes care |
PublicationTitleAlternate | Diabetes Care |
PublicationYear | 2010 |
Publisher | American Diabetes Association |
Publisher_xml | – name: American Diabetes Association |
References | Godsland (2022031302540301300_B18) 2004; 47 Abdul-Ghani (2022031302540301300_B23) 2008; 295 Abdul-Ghani (2022031302540301300_B12) Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. (2022031302540301300_B1) 1997; 20 Gerstein (2022031302540301300_B4) 2007; 78 Abdul-Ghani (2022031302540301300_B8) 2006; 29 Abdul-Ghani (2022031302540301300_B9) 2006; 55 Meyer (2022031302540301300_B13) 2006; 29 Burke (2022031302540301300_B21) 1999; 159 Weyer (2022031302540301300_B10) 1999; 48 Wasada (2022031302540301300_B11) 2004; 47 Stern (2022031302540301300_B19) 1984; 120 Abdul-Ghani (2022031302540301300_B6) 2009; 32 Ferrannini (2022031302540301300_B14) 2003; 46 Kahn (2022031302540301300_B17) 2003; 46 Groop (2022031302540301300_B22) 1996; 45 Unwin (2022031302540301300_B3) 2002; 19 Abdul-Ghani (2022031302540301300_B7) 2008; 31 Stern (2022031302540301300_B20) 1989; 262 Abdul-Ghani (2022031302540301300_B16) 2008; 25 Gastaldelli (2022031302540301300_B24) 2004; 47 Abdul-Ghani (2022031302540301300_B5) 2007; 30 Jani (2022031302540301300_B15) 2008; 31 Shaw (2022031302540301300_B2) 1999; 22 |
References_xml | – volume: 25 start-page: 1289 year: 2008 ident: 2022031302540301300_B16 article-title: Strong association between insulin resistance in liver and skeletal muscle in non-diabetic subjects publication-title: Diabet Med doi: 10.1111/j.1464-5491.2008.02597.x – volume: 120 start-page: 834 year: 1984 ident: 2022031302540301300_B19 article-title: Sex difference in the effects of sociocultural status on diabetes and cardiovascular risk factors in Mexican Americans: the San Antonio Heart Study publication-title: Am J Epidemiol doi: 10.1093/oxfordjournals.aje.a113956 – volume: 78 start-page: 305 year: 2007 ident: 2022031302540301300_B4 article-title: Annual incidence and relative risk of diabetes in people with various categories of dysglycemia: a systematic overview and meta-analysis of prospective studies publication-title: Diabetes Res Clin Pract doi: 10.1016/j.diabres.2007.05.004 – ident: 2022031302540301300_B12 article-title: Impaired early but not late phase insulin secretion in subjects with impaired fasting glucose publication-title: Eur J Clin Invest – volume: 46 start-page: 1211 year: 2003 ident: 2022031302540301300_B14 article-title: Predominant role of reduced β-cell sensitivity to glucose over insulin resistance in impaired glucose tolerance publication-title: Diabetologia doi: 10.1007/s00125-003-1169-6 – volume: 31 start-page: 311 year: 2008 ident: 2022031302540301300_B15 article-title: Decreased non-insulin-dependent glucose clearance contributes to the rise in FPG in the non-diabetic range publication-title: Diabetes Care doi: 10.2337/dc07-1593 – volume: 159 start-page: 1450 year: 1999 ident: 2022031302540301300_B21 article-title: Rapid rise in the incidence of type 2 diabetes from 1987 to 1996: results from the San Antonio Heart Study publication-title: Arch Intern Med doi: 10.1001/archinte.159.13.1450 – volume: 46 start-page: 3 year: 2003 ident: 2022031302540301300_B17 article-title: The relative contributions of insulin resistance and β-cell dysfunction to the pathophysiology of type 2 diabetes publication-title: Diabetologia doi: 10.1007/s00125-002-1009-0 – volume: 19 start-page: 708 year: 2002 ident: 2022031302540301300_B3 article-title: Impaired glucose tolerance and impaired fasting glycemia: the current status on definition and intervention publication-title: Diabet Med doi: 10.1046/j.1464-5491.2002.00835.x – volume: 47 start-page: 758 year: 2004 ident: 2022031302540301300_B11 article-title: Who are more insulin resistant, people with IFG or people with IGT? publication-title: Diabetologia doi: 10.1007/s00125-004-1339-1 – volume: 262 start-page: 360 year: 1989 ident: 2022031302540301300_B20 article-title: Lack of awareness and treatment of hyperlipidemia in type II diabetes in a community survey publication-title: JAMA doi: 10.1001/jama.1989.03430030048032 – volume: 45 start-page: 1585 year: 1996 ident: 2022031302540301300_B22 article-title: Metabolic consequences of a family history of NIDDM (the Botnia study): evidence for sex-specific parental effects publication-title: Diabetes doi: 10.2337/diab.45.11.1585 – volume: 32 start-page: 281 year: 2009 ident: 2022031302540301300_B6 article-title: Fasting versus post load plasma glucose concentration and the risk for future type 2 diabetes: results from the Botnia Study publication-title: Diabetes Care doi: 10.2337/dc08-1264 – volume: 47 start-page: 31 year: 2004 ident: 2022031302540301300_B24 article-title: Beta-cell dysfunction and glucose intolerance: results from the San Antonio metabolism (SAM) study publication-title: Diabetologia doi: 10.1007/s00125-003-1263-9 – volume: 20 start-page: 1183 year: 1997 ident: 2022031302540301300_B1 article-title: Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus publication-title: Diabetes Care doi: 10.2337/diacare.20.7.1183 – volume: 29 start-page: 1909 year: 2006 ident: 2022031302540301300_B13 article-title: Different mechanisms for impaired fasting glucose and impaired postprandial glucose tolerance in humans publication-title: Diabetes Care doi: 10.2337/dc06-0438 – volume: 47 start-page: 1157 year: 2004 ident: 2022031302540301300_B18 article-title: Loss of β cell function as fasting glucose increases in the non-diabetic range publication-title: Diabetologia doi: 10.1007/s00125-004-1454-z – volume: 22 start-page: 399 year: 1999 ident: 2022031302540301300_B2 article-title: Impaired fasting glucose or impaired glucose tolerance. What best predicts future diabetes in Mauritius? publication-title: Diabetes Care doi: 10.2337/diacare.22.3.399 – volume: 55 start-page: 1430 year: 2006 ident: 2022031302540301300_B9 article-title: Insulin secretion and insulin action in subjects with impaired fasting glucose and impaired glucose tolerance: results from the Veterans Administration Genetic Epidemiology Study (VEGAS) publication-title: Diabetes doi: 10.2337/db05-1200 – volume: 48 start-page: 2197 year: 1999 ident: 2022031302540301300_B10 article-title: Metabolic characteristics of individuals with impaired fasting glucose and/or impaired glucose tolerance publication-title: Diabetes doi: 10.2337/diabetes.48.11.2197 – volume: 295 start-page: E401 year: 2008 ident: 2022031302540301300_B23 article-title: The relationship between fasting hyperglycemia and insulin secretion in subjects with normal or impaired glucose tolerance publication-title: Am J Physiol – volume: 30 start-page: 1544 year: 2007 ident: 2022031302540301300_B5 article-title: What is the best predictor for future type 2 diabetes? publication-title: Diabetes Care doi: 10.2337/dc06-1331 – volume: 31 start-page: 1650 year: 2008 ident: 2022031302540301300_B7 article-title: One hour plasma glucose concentration and the metabolic syndrome identify subjects at high risk for future type 2 diabetes publication-title: Diabetes Care doi: 10.2337/dc08-0225 – volume: 29 start-page: 1130 year: 2006 ident: 2022031302540301300_B8 article-title: Contribution of β cell dysfunction and insulin resistance to the pathogenesis of impaired glucose tolerance and impaired fasting glucose publication-title: Diabetes Care doi: 10.2337/dc05-2179 |
SSID | ssj0004488 |
Score | 2.2128894 |
Snippet | OBJECTIVE: To assess the relative contribution of increased fasting and postload plasma glucose concentrations to the incidence of type 2 diabetes in subjects... OBJECTIVE To assess the relative contribution of increased fasting and postload plasma glucose concentrations to the incidence of type 2 diabetes in subjects... To assess the relative contribution of increased fasting and postload plasma glucose concentrations to the incidence of type 2 diabetes in subjects with a... OBJECTIVE - To assess the relative contribution of increased fasting and postload plasma glucose concentrations to the incidence of type 2 diabetes in subjects... |
SourceID | swepub pubmedcentral proquest gale pubmed pascalfrancis crossref fao |
SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 557 |
SubjectTerms | Adult analysis Biological and medical sciences blood blood glucose Blood Glucose - analysis Blood pressure Clinical Medicine complications Dextrose Diabetes Diabetes Mellitus, Type 2 Diabetes Mellitus, Type 2 - blood Diabetes Mellitus, Type 2 - epidemiology Diabetes Mellitus, Type 2 - etiology Diabetes. Impaired glucose tolerance Endocrine pancreas. Apud cells (diseases) Endocrinology and Diabetes Endocrinopathies Endokrinologi och diabetes epidemiology etiology Etiopathogenesis. Screening. Investigations. Target tissue resistance fasting Fasting - blood Female Follow-Up Studies Glucose Glucose Tolerance Test heart Humans Hyperglycemia Hyperglycemia - complications Hyperglycemia - epidemiology Incidence Klinisk medicin logit analysis Male Medical and Health Sciences Medical sciences Medicin och hälsovetenskap Metabolic diseases Middle Aged Miscellaneous noninsulin-dependent diabetes mellitus Original Research Public health. Hygiene Public health. Hygiene-occupational medicine Risk Factors Statistical methods Studies Time Factors Type 2 diabetes Variables |
Title | Minimal Contribution of Fasting Hyperglycemia to the Incidence of Type 2 Diabetes in Subjects With Normal 2-h Plasma Glucose |
URI | https://www.ncbi.nlm.nih.gov/pubmed/20007945 https://www.proquest.com/docview/223039917 https://www.proquest.com/docview/46542821 https://www.proquest.com/docview/733282066 https://pubmed.ncbi.nlm.nih.gov/PMC2827507 https://lup.lub.lu.se/record/1589074 oai:portal.research.lu.se:publications/3f60b1ca-54e2-4f06-83b4-e930c052f0d0 |
Volume | 33 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3db9MwELfYJiEkhPjcwkaxEAJeosV2nI8nNKaWCtRqfFRMvFiO47SV2qQs7QMSfzx3SZotoiAeEqny1bFyl_uw735HyEsTGBYKhtkNWrpYK-kmSZS4CUtiT6eWpREWCo_GwXDif7iUl01uTtmkVW51YqWo08LgHvkpmDEPjCkL365-uNg0Cg9Xmw4ae-QAkcsw9govw-uySL9qO4lBgCvjmNfAQlyI8DQ12AWAYRHTDXO0l-miVc13V7qE15TV_S12OaB_5lF20EYrCzW4T-41riU9q2XhAbll84fk9qg5PH9Efo3m-XwJFIhIte1zRYuMDnSJyc90CDHp1XTx09jlXNN1QcE5pKBA6r6jSIlRK-W0SaMp6TynoHlwK6ek3-brGR2jC7yg3J3RC_DLl5q-r3PiH5PJoP_1fOg2zRdcA07E2o1MwkIThIJLwVPmAyuNTWMmwcKLwEprjUhjHx3CVEsIsKXkBixdHEiujeeLJ2Q_L3J7RKgRNk5lxmFpsQ_TRIalgmkILLmvI2kc8mbLA2UaZHJskLFQEKEguxSyC-unpUNetKSrGo5jF9ERMFLpKahJNfnC8XCWRV7kx8Ihr5G7Cr9eeITRTRECLBRxsNQZhxAtwOIWh7zqUE5rFPBdhCcdQvg8TWe41xGkdtmgSMFXi2KHHG8lSzX6o1SttDvkeTuKM2NKXG6LTakQCA_iZeYQ-heKUAhewfU75LAW1OuHo28Y46sKOyLcEiDqeHckn88q9HGYEgQEFtavhb3zl8VmBVcClyqtElngJcxoJX3LlZ95gYpE4isbC894kmde6jnk-4556thTNYBXs2a-1Y2d7P-a_Ok_3-0xuVPngmBG4QnZX19t7DNwMddJr1IkcI_OWY8cvOuPLz7Dr4-fot9U4n0M |
linkProvider | ProQuest |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3db9MwELe2IQESQnwvbGwW4uslWmzHSfyA0DQ2OrZOSGxi4sU4jrNW6tKydEKT-Jf4H7mr024RBfGyhzz5erFy19_d2fdByAubWJYKhtkNRoZYKxnmeZaHOctVZArHigwLhbsHSeco_ngsjxfIr2ktDKZVTjFxAtTF0OIZ-QaYsQiMKUvfjb6HODQKL1enEzS8Vuy5ix8QsdVvd9-DeF9yvrN9uNUJm6ECoQXjOA4zm7PUJqngUvCCxbBF6wrFJFgukTjpnBWFitHRKYyEwFFKbgHBVSK5sVEsgO8iuRELkWKr_mzrMqMEIp3MZ0yqUCrFfSMjDpQbhcWpAwyLpq6Yv8XSDGem4M7I1CCW0s_TmOfw_pm32epuOrGIO_fI3caVpZte9-6TBVc9IDe7zWX9Q_Kz26_6p0CBHbCmc7XosKQ7psZka9qBGPjsZHBh3Wnf0PGQgjNKAbD8nFOkxCiZctqk7dS0X1FAOjw6qumX_rhHD9DlHlAe9ugniANODf3gc_AfkaNrkctjslQNK7dMqBVOFbLksDUVA5vMskIwA4Esj00mbUDeTGWgbdMJHQdyDDRERCgujeLCem0ZkOcz0pFv_zGPaBkEqc0JwLI--szxMphlURYrEZDXKF2NaAGvsKYpeoCNYt8tvckhJEywmCYgr1qUJ77r-DzC1RYhwIFtLa-1FGm2bQBu8A0zFZCVqWbpBq9qPft3BWR9toqcMQWvcsPzWmPjPYjPWUDoXyhSIfhkPEBAnnhFvXw5-qIKP1XaUuEZAXY5b69U_d6k2zmwBAWBjW17ZW_9ZHA-gieHR9dOizKJcmaNlrHjOi6jRGcij7VTIrKR5GVURAH5OoePj3V102Cr1_AbXTk5_y_mT__5bdfJrc5hd1_v7x7srZDbPg8FsxlXydL47Nw9A_d2nK9NQIWSb9eNYr8B4lOz6Q |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9NAEF61RaqQEOJd09KuEK-LFe-u148DQhVtSCmJKkFE1MuyXq-TSIkT6kSoEn-Mf8dM7KS1CIhLDz55PF55xt_M7M6DkBcmMCwUDLMbtHSxVtJNkihxE5bEnk4tSyMsFG53glbX_9iTvQ3ya1kLg2mVS0xcAHU6MbhH3gAz5oExZWEjq7Iizo6a76bfXRwghQety2kapYac2ssfEL0Vb0-OQNQvOW8ef3nfcqsBA64BQzlzI5Ow0ASh4FLwlPmwXGPTmEmwYiKw0loj0thHpyfVEoJIKbkBNI8DybXxfAF8N8mtUIDVhF8p7IVXJZn-YuQlBiCujGNeNjXiQoSN1OAEAoYFVNdM4WamJyuzcGeqCxBRVs7WWOf8_pnDWet0urCOzXvkbuXW0sNSD--TDZs_INvt6uD-IfnZHubDMVBgN6zljC06yWhTF5h4TVsQD1_0R5fGjoeaziYUHFMK4FXOPEVKjJgpp1UKT0GHOQXUw22kgn4dzga0g-73iHJ3QM8gJhhr-qHMx39Eujcil8dkK5_kdodQI2ycyozD0mIf2ESGpYJpCGq5ryNpHPJmKQNlqq7oOJxjpCA6QnEpFBfWbkuHPF-RTstWIOuIdkCQSvcBolX3M8eDYRZ5kR8Lh7xG6SpEDniF0VUBBCwUe3CpQw7hYYCFNQ55VaPslx3I1xHu1QgBGkzt9n5NkVbLBhAHPzGKHbK71CxVYVehVn-aQw5Wd5EzpuPldjIvFDbhg1idOYT-hSIUgi9GBTjkSamoVy9HvzTGTxXWVHhFgB3P63fy4WDR-RxYgoLAwo5LZa89MppP4UrgUoVVIgu8hBmtpG-58jMvUJFIfGVj4RlP8sxLPYecr-FTxr2qarY1qPhNr-2i_xfzp__8tgdkG_BLfTrpnO6S22VKCiY27pGt2cXcPgNPd5bsLzCFkm83DWK_AQukuEs |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Minimal+Contribution+of+Fasting+Hyperglycemia+to+the+Incidence+of+Type+2+Diabetes+in+Subjects+With+Normal+2-h+Plasma+Glucose&rft.jtitle=Diabetes+care&rft.au=Abdul-Ghani%2C+Muhammad+A&rft.au=Stern%2C+Michael+P&rft.au=Lyssenko%2C+Valeriya&rft.au=Tuomi%2C+Tiinamaija&rft.date=2010-03-01&rft.issn=0149-5992&rft.volume=33&rft.issue=3+p.557-561&rft.spage=557&rft.epage=561&rft_id=info:doi/10.2337%2Fdc09-1145&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0149-5992&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0149-5992&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0149-5992&client=summon |